ANDA 88909, held by Abraxis Pharm. Sodium Chloride.
As of Nov 15, 2026, ANDA 88909 (Bacteriostatic Sodium Chloride 0.9% In Plastic Container), held by Abraxis Pharm, was not approved, with 0 approved supplements and 0 published complete response letters.
| Bacteriostatic Sodium Chloride 0.9% In Plastic Container270MG/30ML (9MG/ML) · solution;injection | Sodium Chloride | Discontinued |
| Bacteriostatic Sodium Chloride 0.9% In Plastic Container90MG/10ML (9MG/ML) · solution;injection | Sodium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
